Compare SUI & RVTY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SUI | RVTY |
|---|---|---|
| Founded | 1975 | 1937 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Laboratory Analytical Instruments |
| Sector | Real Estate | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 15.5B | 13.2B |
| IPO Year | 1993 | N/A |
| Metric | SUI | RVTY |
|---|---|---|
| Price | $127.82 | $114.55 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 13 | 14 |
| Target Price | ★ $137.46 | $113.46 |
| AVG Volume (30 Days) | 596.1K | ★ 1.3M |
| Earning Date | 02-25-2026 | 02-02-2026 |
| Dividend Yield | ★ 3.33% | 0.24% |
| EPS Growth | ★ 324.78 | N/A |
| EPS | ★ 7.94 | 1.99 |
| Revenue | ★ $3,236,900,000.00 | $2,813,367,000.00 |
| Revenue This Year | N/A | $5.30 |
| Revenue Next Year | $5.07 | $3.03 |
| P/E Ratio | ★ $15.73 | $58.83 |
| Revenue Growth | ★ 32.39 | 3.37 |
| 52 Week Low | $109.22 | $81.36 |
| 52 Week High | $137.77 | $128.29 |
| Indicator | SUI | RVTY |
|---|---|---|
| Relative Strength Index (RSI) | 56.50 | 64.40 |
| Support Level | $124.25 | $110.17 |
| Resistance Level | $130.07 | $118.21 |
| Average True Range (ATR) | 2.70 | 4.09 |
| MACD | 0.18 | 0.66 |
| Stochastic Oscillator | 72.32 | 77.75 |
Sun Communities is a residential REIT that focuses on owning manufactured housing and residential vehicle communities. The company currently owns a portfolio of 501 properties, which includes 337 manufactured housing communities and 164 residential vehicle communities. Sun targets owning properties that are desirable as second homes or vacation properties with nearly 50% of the portfolio located in either Florida or Michigan near major bodies of water.
Revvity is a global life sciences and diagnostics company formed in 2023 following the rebranding of PerkinElmer. The company operates in two segments: life sciences, which provides reagents and instruments for biopharma and academic research, and signals software, and diagnostics, which offers tools in immunodiagnostics and newborn and reproductive health. Revvity's products and services are sold worldwide, with major markets in the US, Europe, and China.